Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Andrew P. Keaveny, M.D., studies the management of portal hypertension as well as patient outcomes after liver transplantation. His ongoing research projects include the prediction and management of rejection and renal failure after liver transplantation, the management of vitamin D deficiency before and after transplantation, and the identification of best practices and highest value care of patients undergoing liver transplantation.
Dr. Keaveny works toward better strategies for the diagnosis and management of complications related to end-stage liver disease as well as identifying the optimal practice models in the care of patients needing liver transplantation.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.